Basal breast cancer: a complex and deadly molecular subtype - Test2 - elhamkhani - TriplyDB

Basal breast cancer: a complex and deadly molecular subtype

Basal breast cancer: a complex and deadly molecular subtype

http://www.wikidata.org/entity/Q35931900

about

Sumoylation pathway is required to maintain the basal breast cancer subtype Mammary Development and Breast Cancer: A Wnt Perspective SLUG: Critical regulator of epithelial cell identity in breast development and cancer The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.A murine preclinical syngeneic transplantation model for breast cancer precision medicine.HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Context-Dependent Function of Myoepithelial Cells in Breast Morphogenesis and Neoplasia.Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study.Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis.The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.Basal-like breast cancer: molecular profiles, clinical features and survival outcomes The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.Expression of VEGF and semaphorin genes define subgroups of triple negative breast cancer p16 expression correlates with basal-like triple-negative breast carcinoma Targeting the sumoylation pathway in cancer stem cells Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.On-command drug release from nanochains inhibits growth of breast tumors.ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.Breast cancer complexity: implications of intratumoral heterogeneity in clinical management.A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype.Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.Factors Associated with (18)F-Fluorodeoxyglucose Uptake in T1 and T2 Invasive Ductal Carcinoma of the Breast.Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.

P2860

Q24297866-6C2A478D-101B-4B08-B892-E3A11047087F Q26740086-1D4DD4AC-8470-4F13-9A6B-7DE1EA766779 Q26865846-31007DB3-C494-488D-A465-D8751572C783 Q27005952-F097AC5C-1549-461D-B117-0AD33F1C8209 Q27320934-FFD29A9C-66CE-4A97-8A34-ADC2394C5C1B Q28536791-D1A2C69F-3130-4647-8F0A-4F4DFEE01BBA Q30277772-B3DDCA31-C5AA-4040-A6C5-8EF5302EF359 Q31102636-A83CCE55-215A-4BD3-AF13-F848B4A1D90B Q33580224-F683C51F-875E-4BDB-9477-464795207A4C Q33733042-6A6E6B22-9463-491B-A8A9-1763E2F8170F Q33757096-507EA656-856F-4764-B18B-4AD5254033F4 Q33844032-21D0577A-26EA-4808-B8A6-CB6AFC760FF9 Q34248585-35876EDA-DC5F-4EC4-8536-E3BB3878E420 Q34339847-CD3B51CD-C1FD-40D5-949A-6A03B31A6331 Q34570508-42D175DB-952B-43EE-914C-62BCE6721CB0 Q35185688-97F249BA-9D64-43AE-AB4C-DF0968F4B9CA Q35680116-A13BDBFE-B682-453A-9A13-3F89E9CE448A Q35858759-69020860-4611-4FBA-91D1-4B373EFC6C46 Q36069105-190BFD84-4257-41EC-8B0E-95B958C370FA Q36084803-B2B48150-138E-4751-A1A9-9F91B102B837 Q36325873-D0956082-28F8-43C7-9D3E-FE0CD3912D54 Q36516075-6FEA5339-B280-45F5-BFF5-99CDB95EE3EB Q36540704-C31743A6-F32B-490C-9551-B1A189A0BD91 Q36756685-C8C8488B-AF19-4DAC-A994-245F6243BFED Q36758895-A13FC9D2-C61D-4F0F-B282-45546B24C032 Q36828220-D1CBF82E-200B-419C-A77F-736A457A1DB9 Q36863171-AC55EE56-B9F8-48C8-BAF9-7F5EFAA3668D Q36997628-256A7845-FE4E-4DD1-9DD0-88EE4B2DFBA6 Q37415867-C106C62D-684D-4D9E-B64B-10BE00A35B1A Q37419973-7C80C20E-33DD-4E85-BD36-2D5D9CCEED57 Q37591124-BA02A263-C494-4B6F-B425-95E29C8FCF49 Q37706554-3866270F-47D1-4E44-994B-5ED8A9A2C533 Q38656112-CAA6BA94-F489-4E29-96BB-12D5C7D2CD5C Q38781425-94141CC0-48C2-4BB4-9DEB-FB66B7A8D267 Q38959098-293F200F-0D5D-4C54-A5B1-183041BDC9AB Q38976788-5473136B-C716-4BE6-9239-F76DB656E0EE Q39090194-3A71EAC4-4963-4B7A-98C0-7D860829A2B6 Q39112367-B7B620C2-274C-41FD-B7FC-F6A75C565463 Q41871478-3137EA0A-4E9B-463D-B06D-94BBC2F12307 Q42288449-C96BD733-1D91-4A44-97E5-3F7E0B4CBF07

P2860

Basal breast cancer: a complex and deadly molecular subtype

http://www.wikidata.org/entity/Q35931900

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Basal breast cancer: a complex and deadly molecular subtype

@ast

Basal breast cancer: a complex and deadly molecular subtype

@en

type

label

Basal breast cancer: a complex and deadly molecular subtype

@ast

Basal breast cancer: a complex and deadly molecular subtype

@en

prefLabel

Basal breast cancer: a complex and deadly molecular subtype

@ast

Basal breast cancer: a complex and deadly molecular subtype

@en

P1433

Q35931900-FBF46A0F-426B-44E0-834B-C37C97B979F2

P1476

Q35931900-D7984366-5149-446A-B0B2-91987891EF88

P2093

Q35931900-87C1C028-6710-454E-9AF7-A7B99E6D86E4

Q35931900-DBA39CC2-AA05-4F50-BC03-9D5E2DEABC05

Q35931900-DDA8D30F-5C5C-421D-8813-2DF27E92B9AF

P275

Q35931900-62B0F73A-A6BD-40BB-B19B-AC654DE8B3F9

P2860

Q35931900-00FB84A5-FA4B-4321-B15D-F7D307776326

Q35931900-01566F94-51CC-492F-8D24-C91289C612DC

Q35931900-0443C86D-D826-489B-B8C9-DBA1A46B4A74

Q35931900-04B1DDCB-AC14-4FD1-A2A8-96F0E2F851F9

Q35931900-0599F956-E91D-496D-A670-3FFEE5D5469D

Q35931900-069DA841-EEA6-4B85-8A4F-3166F5709823

Q35931900-07286CB3-999D-432E-B5FF-A4A4B004211C

Q35931900-07B994F7-80B1-4A53-A062-5095F6C3F860

Q35931900-0B7F217F-AC76-43CF-9F68-F46B180B78FE

Q35931900-0C2308FB-C149-4E83-AD78-5F10C64213AA

P304

Q35931900-EDEAEABF-5088-4A88-9F63-14B97111FA18

P31

Q35931900-9B6504DE-1A37-43E4-BEA0-4F602AAC633F

Q35931900-FA9676A7-9737-4A45-929F-78889DE19C90

P356

Q35931900-A7EBBD09-80B7-4D65-A951-49C4D25BC995

P433

Q35931900-C47B2E09-0DBF-43A8-A962-4A8E0011551F

P478

Q35931900-EB1EF5FD-5770-4FE6-B996-776A053BF9C4

P5008

Q35931900-ECE6B93D-2B2C-4E4B-96F9-37630D30857E

P577

Q35931900-C723722B-C39E-41DF-9C71-C8C355275691

P5875

Q35931900-EEBCD380-15BA-4B1B-ABC4-0B1916FBDA7C

P698

Q35931900-A8745C37-E2B3-4970-A002-586534BC199D

P921

Q35931900-AE9B53C9-06D0-4626-8A56-92AB7B6E68BC

Q35931900-B4AA23EC-8F03-4CBD-B99B-03209B712C61

P932

Q35931900-2D693229-2E40-4FB1-BE80-39E010165C05

P356

156652412798376134

P1433

Current Molecular Medicine

P1476

Basal breast cancer: a complex and deadly molecular subtype

@en

P2093

D Birnbaum

http://www.w3.org/2001/XMLSchema#string

F Bertucci

http://www.w3.org/2001/XMLSchema#string

P Finetti

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

ZNF703 gene amplification at 8p12 specifies luminal B breast cancer

Genome-wide association study identifies novel breast cancer susceptibility loci

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

P304

96-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/156652412798376134

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51797399

http://www.w3.org/2001/XMLSchema#string

P698

22082486

http://www.w3.org/2001/XMLSchema#string

P921

basal-cell carcinoma

P932

3343384

http://www.w3.org/2001/XMLSchema#string